• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM Back to Search Results
Catalog Number 12017547122
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/04/2017
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).(b)(4).
 
Event Description
The customer stated that they received erroneous results for one patient sample tested for elecsys insulin (ins) on a cobas 6000 e 601 module (e601).The sample initially resulted as 1.05 uu/ml accompanied by a data flag on the e601 analyzer (reference range = 2.6 - 24.9 uu/ml).The initial value was reported outside of the laboratory.The sample was repeated on the e601 analyzer, resulting as 0.970 uu/ml accompanied by a data flag.On (b)(6) 2017, the sample was repeated on an abbott architect four times, resulting as follows: 227.7 uu/ml, 227 uu/ml, 218 uu/ml, and 228 uu/ml (reference range = 2.0 - 23.0 uu/ml).A sample collected at the same time as the original sample was tested on the e601 analyzer on (b)(6) 2017, resulting as 0.85 uu/ml.Two samples collected at the same time as the original sample were also repeated on the abbott architect analyzer on (b)(6) 2017, with each resulting as 223.9 uu/ml and 206.4 uu/ml.No adverse events were alleged to have occurred with the patient.The e601 analyzer serial number was asked for, but not provided.The customer does not run quality controls daily.
 
Manufacturer Narrative
Calibration signals were within expectations.The last calibration was performed outside of the recommended one month.Control recovery is within specified ranges, but no control data was available from the date of the event.The most likely root cause is that the roche assay does not measure insulin analogues, whereas, cross reactivity to insulin analogues is likely when measured with the abbott architect method.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS INSULIN
Type of Device
IMMUNOREACTIVE INSULIN TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6600496
MDR Text Key76420011
Report Number1823260-2017-01110
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
Reporter Country CodeQA
PMA/PMN Number
K001104
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/31/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number12017547122
Device Lot Number15780501
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age44 YR
-
-